Paratyphoid vaccine

Typhoid vaccine (including typhoid-paratyphoid vaccine)... 

Fu, M.L., Ying, S.C., Wu, M. et al. 2006. Regulating effects of novel CpG chitosan nanoparticles on immune responses of mice to porcine paratyphoid vaccines. Biomed. Environ. Sci. 19 315-322. 

Yang, Y, Chen, J., Li, H. et al. 2007. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comp. Immunol. Microbiol. Irfiect. Dis. 30 19-32. 

There have been individual reports of fatal angio-immunoblastic lymphadenopathy, hemolytic uremic syndrome (after typhoid/paratyphoid/diphtheria vaccination), fatal hyperpyrexia (SED-11, 687), transverse myelitis (SEDA-10, 288), erythema nodosum (SEDA-11,289) (SEDA-14, 281), and Reiter s sjmdrome (SEDA-15, 350). 

BSP retention accompanied by other biochemical abnormalities but without jaundice is common in septicemia (N4). Findings in patients with intrahepatic infection are the same as in those with extrahepatic infection (B54). Reduced BSP handling is common also in malaria (F6, K13, M3). Injections of pyrogens such as typhoid-paratyphoid A and B vaccine (TAB) in man (M3) or bacterial endotoxin in rabbits (H15) cause increased BSP retention (see Section 6.5). 

---